Research & Working Groups

Research and working groups

ACCELERATE actively explores and researches into specific paediatric oncology challenges and propose solutions through its Working Groups. Working Groups are composed of representatives of all the 4 stakeholders plus additional external stakeholder on ad-hoc basis.
The work performed and the results achieved by the ACCELERATE platform working groups are published in peer reviewed journals (see Publications).

Working Groups

Ongoing Working Groups

  • Working Group 5: Fostering Age Inclusive Research (FAIR trials)

    Fostering Age Inclusive Research (FAIR trials)


    Leaders:

    Nathalie Gaspar and Chris Copland


    Start: 2015


    Find out more

  • Working Group 6: Fit for Filing

    Fit for Filing


    Leaders:

    Pamela Kearns and Elly Barry


    Start: 2019


    Find out more

  • Working Group 7: Long-Term Follow-Up

    Long-Term Follow-Up


    Leaders:

    Mark Kieran and Danielle Horton-Taylor


    Start: 2019


    Find out more

  • Working Group 8: International Collaboration

    International Collaboration


    Leaders:

    Gregory Reaman, Nicole Scobie and Teresa De Rojas


    Start: 2020


    Find out more

Terminated Working Groups

  • Working Group 1: New strategies for improved development of oncology drugs for children and adolescent

    New strategies for improved development of oncology drugs for children and adolescent


    Leaders:

    Andy Pearson and Gilles Vassal


    2012 - 2015


    Download PDF

  • Working Group 2: New incentives for specific paediatric drug development and drug repositioning

    New incentives for specific paediatric drug development and drug repositioning


    Leaders:

    Pam Kearns and Patricia Blanc


    2012 - 2015


    Download PDF

  • Working Group 3: Implementation of long-term follow up measures of children and adolescents receiving new anticancer drugs

    Implementation of long-term follow up measures of children and adolescents receiving new anticancer drugs


    Leaders:

    Danielle Horton and Raphaël Rousseau


    2012 - 2015


    Download PDF

  • Working Group 4: Setting Up New Business Models and Ways to Invest in Paediatric Oncology Research and Drug Development

    Setting Up New Business Models and Ways to Invest in Paediatric Oncology Research and Drug Development


    Leaders:

    Delphine Heenen and Sam Blackman


    2016 - 2018


    Download PDF

Share by: